
    
      60 patients with stage III-IV NSCLC will be randomly divided into group A (receive DC-CTL
      treatment with chemotherapy) or group B (Just receive chemotherapy), and the randomize ratio
      will be 1:1, patients in group A will receive 3 cycles of DC-CTL treatment (every 1 months)
      and 4 cycles of chemotherapy (every 2 weeks). Patients in group B will receive only 4 cycles
      chemotherapy(every 2 weeks).
    
  